These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 19515028

  • 1. Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006).
    Chitlur M, Warrier I, Rajpurkar M, Lusher JM.
    Haemophilia; 2009 Sep; 15(5):1027-31. PubMed ID: 19515028
    [Abstract] [Full Text] [Related]

  • 2. Development of anaphylactic shock in haemophilia B patients with inhibitors.
    Warrier I, Lusher JM.
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S125-8. PubMed ID: 9819043
    [Abstract] [Full Text] [Related]

  • 3. Inhibitor development in haemophilia B: an orphan disease in need of attention.
    DiMichele D.
    Br J Haematol; 2007 Aug; 138(3):305-15. PubMed ID: 17614818
    [Abstract] [Full Text] [Related]

  • 4. Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrate.
    Parquet A, Laurian Y, Rothschild C, Navarro R, Guérois C, Gay V, Durin A, Peynet J, Sultan Y.
    Thromb Haemost; 1999 Oct; 82(4):1247-9. PubMed ID: 10544907
    [Abstract] [Full Text] [Related]

  • 5. Induction of immune tolerance using rituximab in a child with severe haemophilia B with inhibitors and anaphylaxis to factor IX.
    Barnes C, Davis A, Furmedge J, Egan B, Donnan L, Monagle P.
    Haemophilia; 2010 Sep 01; 16(5):840-1. PubMed ID: 20546030
    [No Abstract] [Full Text] [Related]

  • 6. Inhibitors in young boys with haemophilia.
    Lusher JM.
    Baillieres Best Pract Res Clin Haematol; 2000 Sep 01; 13(3):457-68. PubMed ID: 11030045
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The North American Immune Tolerance Registry: contributions to the thirty-year experience with immune tolerance therapy.
    Dimichele D.
    Haemophilia; 2009 Jan 01; 15(1):320-8. PubMed ID: 18976249
    [Abstract] [Full Text] [Related]

  • 12. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
    Hay CR, Brown S, Collins PW, Keeling DM, Liesner R.
    Br J Haematol; 2006 Jun 01; 133(6):591-605. PubMed ID: 16704433
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immune tolerance in haemophilia: the long journey to the fork in the road.
    DiMichele DM.
    Br J Haematol; 2012 Oct 01; 159(2):123-34. PubMed ID: 22924753
    [Abstract] [Full Text] [Related]

  • 18. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM.
    Semin Thromb Hemost; 2000 Oct 01; 26(2):179-88. PubMed ID: 10919411
    [Abstract] [Full Text] [Related]

  • 19. Inhibitors in congenital coagulation disorders.
    Key NS.
    Br J Haematol; 2004 Nov 01; 127(4):379-91. PubMed ID: 15521914
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.